UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000022722 |
|---|---|
| Receipt number | R000025921 |
| Scientific Title | An analysis on validity of monitoring by wristwatch-type sphygmograph in detecting of atrial fibrillation |
| Date of disclosure of the study information | 2016/06/13 |
| Last modified on | 2020/06/17 11:23:49 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
An analysis on validity of monitoring by wristwatch-type sphygmograph in detecting of atrial fibrillation
Acronym
CVI ARO 3a study
Scientific Title
An analysis on validity of monitoring by wristwatch-type sphygmograph in detecting of atrial fibrillation
Scientific Title:Acronym
CVI ARO 3a study
Region
| Japan |
Condition
Condition
Paroxysmal or chronic atrial fibrillation requiring 24h ambulatory monitoring
Classification by specialty
| Cardiology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To clarify the degree of coincidence of atrial fibrillation diagnosis between wristwatch-type sphygmograph and 24h ambulatory electrocardiogram
Basic objectives2
Others
Basic objectives -Others
Validation of sphygmographic devise
Trial characteristics_1
Exploratory
Trial characteristics_2
Others
Developmental phase
Not applicable
Assessment
Primary outcomes
The degree of coincidence of atrial fibrillation diagnosis between wristwatch-type sphygmograph and 24h ambulatory electrocardiogram
Key secondary outcomes
None
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Paroxysmal or chronic atrial fibrillation requiring 24h ambulatory monitoring
Key exclusion criteria
Metallic allergy
Target sample size
85
Research contact person
Name of lead principal investigator
| 1st name | Takeshi |
| Middle name | |
| Last name | Yamashita |
Organization
The Cardiovascular Institute
Division name
Director
Zip code
106-0031
Address
3-2-19 Nishiazabu, Minato-Ku, Tokyo. ZIP: 106-0031
TEL
+81-3-3408-2151
yamt-tky@umin.ac.jp
Public contact
Name of contact person
| 1st name | Kazumi |
| Middle name | |
| Last name | Matsuda |
Organization
Cardiovascular Institute Academic Research Organization (CVI ARO)
Division name
Head office
Zip code
106-0031
Address
3-2-19 Nishiazabu, Minato-Ku, Tokyo
TEL
+81-3-3408-2151
Homepage URL
matsuda@cvi.or.jp
Sponsor or person
Institute
The Cardiovascular Institute Academic Organization (CVI ARO)
Institute
Department
Personal name
Funding Source
Organization
Seiko Epson Corporation
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Japan
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Ethical Committee of The Cardiovascular Institute
Address
Nishi-azabu 3-2-19, Minato-ku, Tokyo
Tel
03-3408-2151
matsuda@cvi.or.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
心臓血管研究所付属病院（The Cardiovascular Institute）
Other administrative information
Date of disclosure of the study information
| 2016 | Year | 06 | Month | 13 | Day |
Related information
URL releasing protocol
https://www.cvi.or.jp/kenkyujo/cviaro.html#link01
Publication of results
Published
Result
URL related to results and publications
https://www.cvi.or.jp/kenkyujo/cviaro.html#link01
Number of participants that the trial has enrolled
84
Results
In patient-basis, AF was detected in 28 with Holter, 29 with pulse monitoring out of 84 patients.
In time-interval-basis, AF was detected in 724 with Holter, 682 with pulse monitoring, out of 3660 time intervals.
Results date posted
| 2020 | Year | 06 | Month | 17 | Day |
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
73 paroxysmal AF and 11 chronic AF
Participant flow
Outpatients were recruited
Adverse events
None
Outcome measures
Diagnosis of AF
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2014 | Year | 09 | Month | 19 | Day |
Date of IRB
| 2015 | Year | 04 | Month | 23 | Day |
Anticipated trial start date
| 2015 | Year | 05 | Month | 01 | Day |
Last follow-up date
| 2015 | Year | 10 | Month | 30 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Recruitment and analysis were completed.
Accepted to "Japanese Journal of Electrocardiology" in Mar, 2020.
Management information
Registered date
| 2016 | Year | 06 | Month | 13 | Day |
Last modified on
| 2020 | Year | 06 | Month | 17 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025921
